Nitric oxide contributes to the resistance of young SJL/J mice to experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 176, Issue 1-2, 2006, Pages 1-8

  Staykova, Maria A ^a   Fordham, Susan A ^a   Bartell, Gavin J ^b   Cowden, William B ^b   Willenborg, David O ^a,c  

^a CANBERRA HOSPITAL   (Australia)

^b Biology and Environment   (Australia)

^c The Australian National University   (Australia)

Author keywords

EAE; NO; Sex

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; IMMUNE SYSTEM; INNATE IMMUNITY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STIMULUS RESPONSE;

AGE FACTORS; ANIMALS; ARGINASE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNITY, NATURAL; INTERFERON TYPE II; LYMPH NODES; MALE; MICE; NITRIC OXIDE; NITRIC OXIDE DONORS; REACTIVE NITROGEN SPECIES; SEX CHARACTERISTICS; SPLEEN;

EID: 33746068272     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.03.015     Document Type: Article

References (31)

1. Albina J.E., and Henry Jr. W.L. Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J. Surg. Res. 50 (1991) 403-409
2. Allione A., Bernabei P., Bosticardo M., Ariotti S., Forni G., and Novelli F. Nitric oxide suppresses human T lymphocyte proliferation through IFN-gamma-dependent and IFNgamma-independent induction of apoptosis. J. Immunol. 163 (1999) 4182-4191
3. Andersson A., Kokkola R., Wefer J., Erlandsson-Harris H., and Harris R.A. Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility. J. Leukocyte Biol. 76 (2004) 1118-1124
4. Bebo Jr. B.F., Vandenbark A.A., and Offner H. Male SJL mice do not relapse after induction of EAE with PLP 139-151. J. Neurosci. Res. 45 (1996) 680-689
5. Corraliza I.M., Campo M.L., Soler G., and Modolell M. Determination of arginase activity in macrophages: a micromethod. J. Immunol. Methods 174 (1994) 231-235
6. Cowden W.B., Cullen F.A., Staykova M.A., and Willenborg D.O. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J. Neuroimmunol. 88 (1998) 1-8
7. Cua D.J., Hinton D.R., Kirkman L., and Stohlman S.A. Macrophages regulate induction of delayed-type hypersensitivity and experimental allergic encephalomyelitis in SJL mice. Eur. J. Immunol. 25 (1995) 2318-2324
8. Cua D.J., Hinton D.R., and Stohlman S.A. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J. Immunol. 155 (1995) 4052-4059
9. Dietlin T.A., Hofman F.M., Gilmore W., Stohlman S.A., and van der Veen R.C. T cell expansion is regulated by activated Gr-1+ splenocytes. Cell. Immunol. 235 (2005) 39-45
10. Fillmore P.D., Brace M., Troutman S.A., Blankenhorn E.P., Diehl S., Rincon M., and Teuscher C. Genetic analysis of the influence of neuroantigen-complete Freund's adjuvant emulsion structures on the sexual dimorphism and susceptibility to experimental allergic encephalomyelitis. Am. J. Pathol. 163 (2003) 1623-1632
11. Furlan R., Kurne A., Bergami A., Brambilla E., Maucci R., Gasparini L., Butti E., Comi G., Ongini E., and Martino G. A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis. J. Neuroimmunol. 150 (2004) 10-19
12. Hader W.J., Elliot M., and Ebers G.C. Epidemiology of multiple sclerosis in London and Middlesex County, Ontario, Canada. Neurology 38 (1988) 617-621
13. Levine S., and Sowinski R. Carbonyl iron: a new adjuvant for experimental autoimmune diseases. J. Immunol. 105 (1970) 1530-1535
14. Levine S., and Sowinski R. Allergic encephalomyelitis in the reputedly resistant Brown Norway strain of rats. J. Immunol. 114 (1975) 597-601
15. Nicholson L.B., Murtaza A., Hafler B.P., Sette A., and Kuchroo V.K. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9279-9284
16. O'Brien N.C., Charlton B., Cowden W.B., and Willenborg D.O. Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease. J. Immunol. 167 (2001) 5904-5912
17. Palaszynski K.M., Loo K.K., Ashouri J.F., Liu H.B., and Voskuhl R.R. Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol. 146 (2004) 144-152
18. Papenfuss T.L., Rogers C.J., Gienapp I., Yurrita M., McClain M., Damico N., Valo J., Song F., and Whitacre C.C. Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J. Neuroimmunol. 150 (2004) 59-69
19. Sadovnick A.D., and Ebers G.C. Epidemiology of multiple sclerosis: a critical overview. Can. J. Neurol. Sci. 20 (1993) 17-29
20. Smith M.E., Eller N.L., McFarland H.F., Racke M.K., and Raine C.S. Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis. Am. J. Pathol. 155 (1999) 1147-1161
21. Staykova M.A., Cowden W., and Willenborg D.O. Macrophages and nitric oxide as the possible cellular and molecular basis for strain and gender differences in susceptibility to autoimmune central nervous system inflammation. Immunol. Cell Biol. 80 (2002) 188-197
22. Staykova M.A., Berven L.A., Cowden W.B., Willenborg D.O., and Crouch M.F. Nitric oxide induces polarization of actin in encephalitogenic T cells and inhibits their in vitro transendothelial migration in a p70S6 kinase-independent manner. FASEB J. 17 (2003) 1337-1339
23. Staykova M.A., Paridaen J.T., Cowden W.B., and Willenborg D.O. Nitric oxide contributes to resistance of the Brown Norway rat to experimental autoimmune encephalomyelitis. Am. J. Pathol. 166 (2005) 147-157
24. Stohlman S.A., Matsushima G.K., Casteel N., and Frelinger J.A. The defect in delayed-type hypersensitivity of young adult SJL mice is due to a lack of functional antigen-presenting cells. Eur. J. Immunol. 15 (1985) 913-916
25. Stohlman S.A., Pei L., Cua D.J., Li Z., and Hinton D.R. Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10. J. Immunol. 163 (1999) 6338-6344
26. Taylor-Robinson A.W., Liew F.Y., Severn A., Xu D., McSorley S.J., Garside P., Padron J., and Phillips R.S. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24 (1994) 980-984
27. van der Veen R.C., Dietlin T.A., Dixon Gray J., and Gilmore W. Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells. Cell. Immunol. 199 (2000) 43-49
28. Voskuhl R.R. Gender issues and multiple sclerosis. Curr. Neurol. Neurosci. Rep. 2 (2002) 277-286
29. Voskuhl R.R., Pitchekian-Halabi H., MacKenzie-Graham A., McFarland H.F., and Raine C.S. Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann. Neurol. 39 (1996) 724-733
30. Willenborg D.O., Fordham S.A., Staykova M.A., Ramshaw I.A., and Cowden W.B. IFNgamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J. Immunol. 163 (1999) 5278-5286
31. Willenborg D.O., Staykova M.A., and Cowden W.B. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review. J. Neuroimmunol. 100 (1999) 21-35